QA: Atheronova Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001377053_2013_Atheronova_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Excluding company: variable exceeds outlier threshold pre-agg {'variable': 'Expenses', 'value': 11727731, 'size_variable': 'Assets', 'size_value': 308830, 'ratio': 38.0, 'threshold': 20}

Graph

Absolute values for 0001377053, Atheronova Inc

  xvar xval
0 AssetsCurrent 2,761,668
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,514
3 remainder_Assets 23,777
4 LiabilitiesCurrent 640,645
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,365
11 remainder_Revenues 0
12 remainder_NetIncome -2,634,196
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,793,959
1 Liabilities 640,645
2 Expenses 1,365
3 Revenues 0
4 StockholdersEquity 2,153,314
5 NetIncome -2,635,561
6 ComprehensiveNetIncome -2,635,561
7 BaseVar 3,035,082
8 EconomicCapitalRatiobeforeLimitedLiability 1.20
9 EconomicCapitalRatio 2.46

Edgar->Model Mapping

Feature Distribution

Change over Time